Advanced Renal Technologies

Private Company, Headquarters Location
40 Lake Bellevue Dr., Ste. 100, Bellevue, WA 98005, United States
(800)346-2080, (425)453-8777, (425)451-9438 fax, http://www.citrasate.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Biological Products Except Diagnostic

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Advanced Renal Technologies, News and Information

Yale's scan of Turkish infant's genome yields a surprise diagnosis.
NewsRx Science; 11/8/2009; 901 words; ...of emerging genetic technologies, Yale University researchers...and, as cost of the technology decreases, will be...approach is a marriage of advanced DNA sequencing technology and microarray protocols...doctor, they used technology to conduct a genetic...caused by mutations in renal ...

Other News To Note.
BIOWORLD Today; 11/4/2009; 3567 words; ...additional targets. o Advanced Magnetics Inc...cancer. o Argonaut Technologies Inc., of Foster...efforts. o Caliper Technologies Corp., of Mountain...siRNA gene-silencing technology to cultured mouse...April licensed RNAi technology from the medical school...initial platelet count, ...

Inex Presents Interim NHL Trial Results With 100% Response.
BIOWORLD Today; 11/4/2009; 2524 words; ...s liposomal drug delivery technology, Transmembrane Carrier System...its two Phase III trials in renal-cell carcinoma with Neovastat...of BNP7787 in patients with advanced non-small-cell lung cancer...chemoprotecting agent. Bio-Technology General Corp., of Iselin...

QUARK PHARMA TO PRESENT DATA ON ITS SIRNA THERAPEUTIC PROGRAMS.
AsiaPulse News; 11/3/2009; 1228 words; ...delayed graft function (DGF) following renal transplantation. Both studies are scheduled...to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry...developed by Quark, is being evaluated in advanced IND-enabling preclinical studies as...

Kosan's Offering Brings In $39.4M For R&D Work.
BIOWORLD Today; 11/3/2009; 969 words; ...or invest in businesses, products and technologies. Kosan focuses on cancer products and...for melanoma, lymphoma, and breast, renal and thyroid cancers, as well as Phase...an NCI-sponsored Phase I study for advanced malignancies, and a Kosan-sponsored...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.